Transocean Ltd vs Tilray Brands Inc — how do they compare? Transocean Ltd trades at $5.79 (market cap $6.38B), while Tilray Brands Inc trades at $4.21 (market cap $577.15M). The key difference: Transocean Ltd is far larger — about 11.1× Tilray Brands Inc's market cap, and Transocean Ltd is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| RIG | TLRY | |
|---|---|---|
Market Cap | $6.38B | $577.15M |
Sector | Technology | Health |
52-Week High | $7.58 | $21.00 |
52-Week Low | $3.08 | $3.88 |
Enterprise Value | $10.99B | $744.29M |
Signals from Pluang's Aura AI — not financial advice
Transocean (RIG) trades at $5.76, down 1.54% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported a Q2 2026 earnings beat with EPS of $0.15 versus $0.00982 expected, though revenue declined year-over-year. Recent news highlights a $300 million contract award from ONGC and improved cash flow, yet high debt and interest costs remain concerns. Analyst consensus is mixed with 39% buy, 39% hold, and 22% sell ratings.
RIG offers exposure to rising oil prices and deepwater drilling demand, supported by a strong contract backlog and operational efficiency. However, persistent net losses, high leverage, and volatile earnings pose significant risks. The stock's valuation appears modest with a P/S of 1.5 and P/B of 0.76, but profitability metrics are weak, requiring careful risk assessment for investment.
TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.
TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.
Trailing returns across standard periods
Latest headlines on both assets
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →